Clinical Trials Browser

Phase 2 × Squamous Cell Carcinoma of Head and Neck × dalpiciclib × Clear all

NCT06199271 2024-01-22

Neoadjuvant Adebrelimab Plus Dalpiciclib in Head and Neck Squamous Cell Carcinoma

Phase 2 Not yet recruiting

Squamous Cell Carcinoma of Head and Neck